TABLE 1.
Baseline characteristics of patients
| Patient demographics | n = 48 |
|---|---|
| Gender | |
| Male | 43 (89.6%) |
| Female | 5 (10.4%) |
| Type of cancer | |
| Head and neck cancer | 41 (85.41%) |
| Prostate cancer | 7 (14.59%) |
| Median (range) | |
|---|---|
| Age, years | 44 (24–79) |
| Body surface area, m2 | 1.64 (1.1–2.0) |
| Dose, mg | 120 (65–150) |
| Serum creatinine, mg/dl | 0.9 (0.6–1.4) |
| Creatinine clearance, ml/min | 86.55 (32.89–131.5) |
| Albumin, g/dl | 4.1 (2.8–5.2) |
| Aspartate transaminase, IU/L | 22 (11–57) |
| Alanine transaminase, IU/L | 26 (9–90) |
| Alkaline phosphatase, IU/L | 113 (55–382) |
| Serum bilirubin, mg/dl | 0.58 (0.39–1.3) |